Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T20:16:08.294Z.
Calculation as of: 2026-10-06T20:16:08.294Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Market Cap
$95.14M
PB Ratio
5.22
TTM Avg
5.69
3Y Avg
4.44
5Y Avg
3.58
Market Cap
$93.96M
PB Ratio
3.15
TTM Avg
3.63
3Y Avg
3.63
5Y Avg
3.63
Market Cap
$103.14M
PB Ratio
1.07
TTM Avg
1.27
3Y Avg
1.48
5Y Avg
1.20
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $97.94M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | 18.17 | 9.67 | 65.57 | 39.31 |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | 0.94 | 1.64 | 1.90 | 1.94 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | 0.58 | 0.65 | 0.86 | 0.86 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | 5.22 | 5.69 | 4.44 | 3.58 |
| The Joint Corp. (JYNT)vs › | $101.36M | 6.39 | 7.09 | 7.05 | 9.80 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | 3.15 | 3.63 | 3.63 | 3.63 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | 7.10 | 7.02 | 5.52 | 4.82 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | 1.07 | 1.27 | 1.48 | 1.20 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 0.72 | 0.68 | 0.90 | 1.31 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
